...
首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >Limiting factors for autologous transplantation among transplant-eligible multiple myeloma patients: Lesson from a Tertiary Cancer Centre in rural India
【24h】

Limiting factors for autologous transplantation among transplant-eligible multiple myeloma patients: Lesson from a Tertiary Cancer Centre in rural India

机译:流动符合条件多发性骨髓瘤患者自体移植的限制因素:印度农村三级癌症中心的课程

获取原文
获取原文并翻译 | 示例
           

摘要

There is limited data from low and middle income countries on the exact proportion of Myeloma patients undergoing transplant even if they are eligible for the same. In this retrospective analysis of all newly diagnosed transplant eligible Myeloma treated between January 2011 to June 2017, number of patients undergoing transplant were recorded and among those not opting for transplant, reasons for the same were noted. Among 89 eligible patients, 23 (26%) patients could undergo transplantation. Most common reasons for not undergoing transplant were fear of the complications in 42 (47%) and financial reasons in 41 (46%) of patients. The transplanted group had better progression free survival when compared against the non-transplanted group (3 year PFS of 80% versus 36%, HR = 0.09, 95%CI 0.02-0.4, p = 0.001). Future studies may be conducted to arrive at measures, for correcting the transplant related concerns and fears, through psycho-social interventions.
机译:中低收入国家的数据有限,即使他们有资格接受移植的骨髓瘤患者的确切比例也有限。 在2011年1月至2017年1月至6月间预处理的所有新诊断的移植符合条件的义群体的回顾性分析中,记录了正在进行移植的患者的数量,并且在未选择移植的人中,注意到的原因是指出的。 在89名符合条件的患者中,23例(26%)患者可能会发生移植。 未发生移植的最常见原因是担心42(47%)和41名(46%)患者的财务原因的并发症。 与非移植组比较(3年PFS对36%的36%,HR = 0.09,95%CI 0.02-0.4,P = 0.001)相比,移植组具有更好的进展自由生存期。 未来的研究可能会通过心理社会干预措施来衡量措施,以纠正移植相关的关注和恐惧。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号